PALI
#3180
Palisade Bio, Inc. - Common Stock
2.0 1 USD
-0.04%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-4.29%
Variación mensual
+2.55%
Variación en los últimos 6 meses
+10.44%
Cambio anual
+18.24%
Cierres anteriores
2.1 0
Open
2.0 5
Mínimo
2.0 1
Máximo
2.0 5
Volumen
515
Financials
- Market Capitalization 350.28 M
- Employee 14
- Founded 2005
- CEO N/A
- Website www.palisadebio.com
- Headquarter Delaware, United States
- FIGI BBG000QG4DJ2
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
3.22
Relación precio/flujo de caja
883.58
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 3120 |  IPSC Century Therapeutics, Inc. - Common Stock | 2.12 USD | +2.42% | +8.72% | -0.93% | +285.45% | 383.88 M USD | ||
| 3151 |  LYEL Lyell Immunopharma, Inc. - Common Stock | 14.71 USD | -5.28% | +8.56% | +15.19% | -39.19% | 360.47 M USD | ||
| 3192 |  DMAC DiaMedica Therapeutics Inc. - Common Stock | 6.51 USD | -0.15% | -1.66% | -4.12% | +8.14% | 351.06 M USD | ||
| 3194 |  IKT Inhibikase Therapeutics, Inc. - Common Stock | 2.50 USD | +4.60% | +4.60% | +5.93% | +34.41% | 348.84 M USD |